Angion Biomedica (ANGN) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free ANGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAngion Biomedia Corp. Announces 1-for-10 Reverse Stock Splitfinance.yahoo.com - June 1 at 10:22 AM8-K: Angion Biomedica Corp.marketwatch.com - May 2 at 2:30 PMCompanies Like Angion Biomedica (NASDAQ:ANGN) Could Be Quite Riskyfinance.yahoo.com - April 27 at 7:47 AMSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVAmarkets.businessinsider.com - April 11 at 3:11 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIGmarkets.businessinsider.com - April 6 at 1:07 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, DCT, ANGNstockhouse.com - March 4 at 5:21 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, OSH, IAAstockhouse.com - February 24 at 9:21 PMMoore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law Firmbenzinga.com - January 22 at 7:00 AMSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Angion Biomedica Corp. - ANGNbenzinga.com - January 18 at 11:04 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Angion Biomedica Corp. Mergerbenzinga.com - January 17 at 8:59 PMAngion Biomedica Shares Tumble Premarket on Elicio Tie-Up >ANGNmarketwatch.com - January 17 at 3:58 PMANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholderstechnews.tmcnet.com - January 17 at 10:58 AMBullish insiders bet US$857k on Angion Biomedica Corp. (NASDAQ:ANGN)finance.yahoo.com - December 27 at 1:06 PMAngion Biomedica Corp.: Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirementsfinanznachrichten.de - December 22 at 7:35 AMAngion Receives Nasdaq Notice Regarding Minimum Bid Price Requirementsfinance.yahoo.com - December 22 at 12:52 AMNabriva (NBRV) Posts Positive Data From Cystic Fibrosis Studynasdaq.com - November 29 at 8:58 PMAxsome (AXSM) Gains as Alzheimer's Agitation Study Meets Goalnasdaq.com - November 29 at 8:58 PMReasons to Add Immunovant (IMVT) Stock to Your Portfolio Nowmsn.com - November 24 at 12:58 PMImmunovant (IMVT) Rises More Than 150% in 3 Months: Here's Hownasdaq.com - November 17 at 2:24 PMJazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive Salesfinance.yahoo.com - November 10 at 4:46 PMKaruna Therapeutics (KRTX) Posts Wider-Than-Expected Q3 Lossfinance.yahoo.com - November 4 at 4:37 PMLilly (LLY) Beats on Q3 Earnings & Sales, Lowers '22 Viewfinance.yahoo.com - November 1 at 7:38 PMIs Angion Biomedica (NASDAQ:ANGN) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - October 13 at 5:59 PMAngion Biomedica Corp. (ANGN)finance.yahoo.com - September 24 at 11:10 AMAngion Biomedica's Return On Capital Employed Overviewmsn.com - September 12 at 6:40 PMAngion Biomedica Corp Ordinary Sharesmorningstar.com - September 9 at 10:54 PMRecap: Angion Biomedica Q2 Earningsbenzinga.com - August 17 at 9:43 PMAngion Provides Corporate Update and Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 15 at 6:37 PMAngion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Valuefinance.yahoo.com - July 25 at 7:21 PMmarketbeat.com - July 25 at 4:27 PMHC Wainwright Downgrades Angion Biomedicafinance.yahoo.com - July 18 at 7:28 PMAngion Biomedica Corp Ordinary Shares - Stock Quote ANGNmorningstar.com - July 1 at 11:40 PMAngion Biomedica Shares Plumb New Depths After Study Setback >ANGNmarketwatch.com - July 1 at 11:40 PMAngion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Whyfinance.yahoo.com - June 30 at 5:57 PMAngion Biomedica shares dive after kidney-disease drug trial discontinuedfinance.yahoo.com - June 29 at 9:53 PMAngion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney Diseasefinance.yahoo.com - June 29 at 4:52 PMAngion to discontinue phase 2 trial of ANG-3070 in patients with kidney diseaseseekingalpha.com - June 29 at 4:52 PMmarketbeat.com - June 29 at 4:09 PMJay Venkatesan Is The President of Angion Biomedica Corp. (NASDAQ:ANGN) And They Just Picked Up 5.7% More Sharesfinance.yahoo.com - May 28 at 9:41 AMAngion Provides Corporate Update and Reports First Quarter 2022 Financial Resultsfinance.yahoo.com - May 16 at 7:54 PMAngion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosisfinance.yahoo.com - May 16 at 1:58 AM5 Biotech Stocks Set to Outpace Q1 Earnings Estimatesfinance.yahoo.com - May 11 at 8:58 AMHere's Why We're Watching Angion Biomedica's (NASDAQ:ANGN) Cash Burn Situationfinance.yahoo.com - May 6 at 1:10 PMAngion Announces Participation in Upcoming Investment Conferencefinance.yahoo.com - April 14 at 8:59 PMAngion Biomedica GAAP EPS of -$1.93, revenue of $28.31Mseekingalpha.com - April 1 at 8:36 PMAngion Provides Corporate Update and Reports Full Year 2021 Financial Resultsfinance.yahoo.com - March 30 at 6:02 PMPrecision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimatesmsn.com - March 15 at 10:28 AMEvogene (EVGN) Reports Q4 Loss, Tops Revenue Estimatesnasdaq.com - March 10 at 1:12 PMShareholders in Angion Biomedica (NASDAQ:ANGN) are in the red if they invested a year agofinance.yahoo.com - March 6 at 10:08 AMAngion Announces Participation in Upcoming Investment Conferencesfinance.yahoo.com - February 28 at 8:19 PM Get Angion Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. ANGN Media Mentions By Week ANGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGN News Sentiment▼0.000.45▲Average Medical News Sentiment ANGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGN Articles This Week▼00▲ANGN Articles Average Week Get Angion Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Acasti Pharma News Today Freeline Therapeutics News Today LianBio News Today Lipocine News Today Brainstorm Cell Therapeutics News Today Alaunos Therapeutics News Today ZIVO Bioscience News Today T2 Biosystems News Today SAB Biotherapeutics News Today Celyad Oncology News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Angion Biomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
